Life-saving FIP treatment is here! Learn about Bova GS-441524 from Stokes Pharmacy for your practice & patients.

epicur logo
epicur logo

Now Available in the U.S. & Ready to Ship!

Injectable Omeprazole for Horses

Changing the game for equine gastric ulcers. Over 200,000 doses sold globally!

We have partnered with the Bova group to bring a unique formulation of omeprazole injection for horses to the US. This is the same omeprazole injection that Bova has used in Australia and the UK since 2017.

Benefits of Omeprazole Injection Suspension

Epicur Bova Omeprazole

Order today!

We offer two simple, streamlined ways to order our Omeprazole Injection Suspension for your patients and practice. 

  • Online via iFill

    Current iFill users will be able to place an order online. This is our most recommended way of ordering. View pricing, expiration dates, and order seamlessly!

    If you're a new user, register for an account.*
    *registration for iFill takes up to 48 hours

  • Call Your Order In

    Veterinarians can also call Epicur at
    (888) 508-5032

Additional Equine Medications from Stokes Pharmacy

Our sister division, Stokes Pharmacy also has select medications available for horse health, including Ertugliflozin, Esomeprazole, and Doxycycline Monohydrate. Learn more about available medications. 

Downloads and Resources

Omeprazole Injection Drug Information Sheet
About the Bova formulation of injectable omeprazole manufactured at Epicur Pharma
Get My Copy
Omeprazole Injection Brochure
Learn more, including the differences between this formulation as well as other formulations available on the market
Download Now

Upcoming and On-Demand Equine Webinars

Updates on the Treatment of Equine Gastric Disease

January 8  | 4 p.m. ET

RACE-Approved CE Credit Hours: 1
Free to attend

An upcoming webinar will highlight recent developments in the management of both squamous and glandular gastric disease, reviewing recent publications in the context of existing knowledge. Attendees will gain an understanding of the limitations of oral proton pump inhibitors and explore advances in newer generation PPIs, including extended-release injectable omeprazole. The session will also cover the published evidence supporting a range of treatment options for gastric disease.

Save My Seat

Injectable Omeprazole in Horses with Gastric Ulcers

November 6 | 8 p.m. ET

RACE-Approved CE Credit Hours: 1
Free to attend

This webinar will review the anatomy of the equine stomach, the classification of gastric ulcers, and current treatment options, including their limitations. It will also highlight a study on the efficacy of a long-acting injectable omeprazole for treating both non-glandular and glandular gastric ulcers in horses.

Save My Seat

A Practical Guide To Incorporating Injectable Omeprazole into Your Practice

This webinar reviewed literature on injectable vs. oral omeprazole, highlighted case examples on benefits, techniques, and complications, compared recommendations with clinical experience, and covered regulatory requirements for prescribing and stocking injectable omeprazole in equine clinics.

Watch Now

Equine Thyroid Disorders and Supplements, What Do We Need to Know?

This session reviewed the equine thyroid disorders and the evidence behind thyroid hormone supplementation. Thyroid disorders are rare, and supplementation can be detrimental.

Watch Now

Equine Gastric Ulcer Syndrome: Prevention, Management, and Recent Treatment Advances

Watch our latest presentation exploring key management practices for Equine Gastric Ulcer Syndrome (EGUS), strategies that support both prevention and treatment. We also highlight some of the most promising therapeutic advancements introduced over the past 5 to 10 years.

Watch Now

It’s Not Just About the Horses: Human Behavior and the Key to Veterinary Success

This talk will introduce theories of human behavior change as they apply to veterinary medicine, explaining how you can use the findings from this scientific field when communicating with clients, in order to build good client relationships and further improve the welfare of animals in your care.

Watch It Now

Clinical Studies

Published March 2023
Five versus seven-day dosing intervals of extended-release injectable omeprazole in the treatment of equine squamous and glandular gastric disease

Published September 2024
Pharmaceutical treatment of equine glandular gastric disease: A contextualised review of recent developments

Published September 2018
Efficacy of long-acting injectable omeprazole (LAIOMEP) in the management of equine glandular gastric disease (EGGD) and equine squamous gastric disease (ESGD)

Published January 2020
A study investigating the treatment of equine squamous gastric disease with long-acting injectable or oral omeprazole.

Get ahead of the herd.

Subscribe to Epicur Pharma & Stokes Pharmacy updates!

Become a Stokes Healthcare subscriber to stay up to date on all the latest product announcements, company news, industry updates, and veterinary care best practices.

Disclaimer: By signing up, you are agreeing to receive emails from both Epicur Pharma and Stokes Pharmacy, two divisions of Stokes Healthcare.

Epicur Pharma and Bova Partnership

In 2022, Stokes Healthcare formed a partnership with Bova Global which would bring their unique formulations of medications to the US.

The Bova Group comprises Bova Aus and Bova UK. Bova Aus has been operational since 1968 and is the largest veterinary compounder in Australia, catering to numerous veterinarians nationwide. Bova Aus has implemented a robust quality assurance system for popular, high-risk, and complex compounded products in collaboration with the Australian Pesticides and Veterinary Medicines Authority (APVMA) to ensure compliance with prevailing regulations, adhering to USP or BP pharmacopoeia standards for quality control.

In 2017, Bova expanded operations to the UK with Bova UK, a Specials Manufacturer focused on delivering high-quality Specials Medications to the UK veterinary sector. Authorized by the Veterinary Medicines Directorate, the facilities obtained a Manufacturer ‘Specials’ Authorisation (ManSA) in 2017 for both sterile and non-sterile medicines. The company upholds stringent quality standards compliant with current Good Manufacturing Practices (cGMP) and Good Laboratory Practices (GLP) as outlined by the European Medicine Standards. 

Made possible by our partnership, Epicur Pharma is manufacturing the only injectable omeprazole formulation identical to the Bova formulation used in clinical studies across the globe. 

When I was looking for a partner to bring our unique formulations to the US, it was critical to me to find a partner that took science and quality as serious as Bova does. When I met the team at Stokes, I couldn’t have been happier. I’ve been to the facilities several times to inspect them, and I can assure you they are taking this extremely seriously. After they made the product, they sent it to us to assure that they were meeting the Bova specifications. So you can be confident in the quality of the medicines that are produced at Stokes Healthcare.
Nick Bova
CEO of Bova Global

Why Partner With Us

As we work to raise the standard of care in animal health through the medications we manufacture, Epicur is dedicated to helping veterinary professionals advance the industry and improve patient care. 

  • Over 45 years in the veterinary market
  • Single source for direct to client or direct to office orders
  • Trusted industry thought leader for free webinars for CE credit, blogs and white papers
  • Sponsor and supporter of hospital CE programs
  • Advisors on industry trends & guidances
  • Streamlined ordering processes via phone or online via iFill
  • Most orders ship same day with only 1-2 business days in transit

Our Family of Brands

Stokes Healthcare has prepared medications for your individual patients since 1975 through Stokes Pharmacy. Recognizing the evolving needs of veterinary practices as regulations and
laws changed, including GFI 256 and USP guidelines, we expanded to include Epicur Pharma to serve the needs of many of your patients with standardized and tested bulk medications.

Each of our brands operates with key differences that impact your patient care and influence treatment plans, but they are all unified in their commitment to quality and improving patient outcomes with medication you trust. You can be confident in your patient care when you partner with us, knowing there is consistency and reliability in every medication.

Patient Orders:
800.754.5222

Office Orders:
888.508.5032 or dto@epicurpharma.com